Table 3.
Proportion of multi-drug resistant isolates along with the ESBL+ rate between genders and age groups.
Frequency MDR isolates (%) | EBSL+ rate (%) | ||
---|---|---|---|
Gender | Males (n = 39) | 66 | 43 |
Females (n = 20) | 34 | 22 | |
Age group | 0–12 years (n = 36) | 61 | 41 |
20–49 years (n = 8) | 14 | 7 | |
50+ years (n = 15) | 25 | 17 |